(Q37114383)

18 August 2017

1 reference

title

Treatment of hypercalcaemia of malignancy with clodronate (English)

1 reference

18 August 2017

1 reference

https://api.crossref.org/works/10.1016/8756-3282(91)90062-N

6 December 2022

author name string

J. P. Bonjour

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1835397

6 December 2022

R. Rizzoli

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1835397

6 December 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1835397

6 December 2022

publication date

1 January 1991

1 reference

full work available at URL

18 August 2017

https://api.elsevier.com/content/article/PII:875632829190062N?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/8756-3282(91)90062-N

https://api.elsevier.com/content/article/PII:875632829190062N?httpAccept=text/plain

6 December 2022

1 reference

https://api.crossref.org/works/10.1016/8756-3282(91)90062-N

6 December 2022

1 reference

18 August 2017

volume

12 Suppl 1

1 reference

18 August 2017

page(s)

S19-23

1 reference

Parathyroid hormone and renal handling of Pi: effect of dietary Pi and diphosphonates

18 August 2017

cites work

5

1 reference

https://api.crossref.org/works/10.1016/8756-3282(91)90062-N

Bone and renal components in hypercalcemia of malignancy and responses to a single infusion of clodronate.

6 December 2022

6

1 reference

https://api.crossref.org/works/10.1016/8756-3282(91)90062-N

Pathophysiological aspects and therapeutic approaches of tumoral osteolysis and hypercalcemia

6 December 2022

7

1 reference

https://api.crossref.org/works/10.1016/8756-3282(91)90062-N

Increased serum levels of a parathyroid hormone-like protein in malignancy-associated hypercalcemia

6 December 2022

11

1 reference

https://api.crossref.org/works/10.1016/8756-3282(91)90062-N

Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer

6 December 2022

12

1 reference

https://api.crossref.org/works/10.1016/8756-3282(91)90062-N

Bisphosphonates directly inhibit the bone resorption activity of isolated avian osteoclasts in vitro

6 December 2022

13

1 reference

https://api.crossref.org/works/10.1016/8756-3282(91)90062-N

Effects of disodium dichloromethylene diphosphonate on hypercalcemia produced by bone metastases

6 December 2022

14

1 reference

https://api.crossref.org/works/10.1016/8756-3282(91)90062-N

Long-Term Effects of Dichloromethylene Diphosphonate (Cl2 DP) on skeletal Lesions in Multiple Myeloma

6 December 2022

16

1 reference

https://api.crossref.org/works/10.1016/8756-3282(91)90062-N

Long term effects of dichloromethylene diphosphonate in Paget's disease of bone

6 December 2022

17

1 reference

https://api.crossref.org/works/10.1016/8756-3282(91)90062-N

Effect of dichloromethylene diphosphonate in Paget's disease of bone and in hypercalcaemia due to primary hyperparathyroidism or malignant disease

6 December 2022

18

1 reference

https://api.crossref.org/works/10.1016/8756-3282(91)90062-N

Dichloromethylenebisphosphonate (Cl2MBP) inhibits bone resorption through injury to osteoclasts that resorb Cl2MBP-coated bone

6 December 2022

19

1 reference

https://api.crossref.org/works/10.1016/8756-3282(91)90062-N

The influence of two diphosphonates on calcium metabolism in the rat

6 December 2022

21

1 reference

https://api.crossref.org/works/10.1016/8756-3282(91)90062-N

Secondary Hyperparathyroidism Associated with Dichloromethane Diphosphonate Treatment of Paget's Disease*

6 December 2022

22

1 reference

https://api.crossref.org/works/10.1016/8756-3282(91)90062-N

Suppression of parathyroid secretion after administration of WR-2721 in a patient with parathyroid carcinoma

6 December 2022

24

1 reference

https://api.crossref.org/works/10.1016/8756-3282(91)90062-N

Comparison of two parenteral diphosphonates in hypercalcemia of malignancy

6 December 2022

27

1 reference

https://api.crossref.org/works/10.1016/8756-3282(91)90062-N

Use of Dichloromethylene Diphosphonate in Metastatic Bone Disease

6 December 2022

28

1 reference

https://api.crossref.org/works/10.1016/8756-3282(91)90062-N

Effects of intravenous diphosphonates on renal function

6 December 2022

29

1 reference

https://api.crossref.org/works/10.1016/8756-3282(91)90062-N

The use of dichloromethylene diphosphonate for the management of hypercalcaemia in multiple myeloma

6 December 2022

34

1 reference

https://api.crossref.org/works/10.1016/8756-3282(91)90062-N

Mechanism of malignant hypercalcaemia in carcinoma of the breast

6 December 2022

35

1 reference

https://api.crossref.org/works/10.1016/8756-3282(91)90062-N

Effect of synthetic tumoral PTH-related peptide on cAMP production and Na-dependent Pi transport

6 December 2022

36

1 reference

https://api.crossref.org/works/10.1016/8756-3282(91)90062-N

Role of bone and kidney in parathyroid hormone-related peptide-induced hypercalcemia in rats

6 December 2022

37

1 reference

https://api.crossref.org/works/10.1016/8756-3282(91)90062-N

High extracellular calcium increases the production of a parathyroid hormone-like activity by cultured Leydig tumor cells associated with humoral hypercalcemia

6 December 2022

39

1 reference

https://api.crossref.org/works/10.1016/8756-3282(91)90062-N

Effect of ethane-1-hydroxy-1,1-diphosphonate (EHDP) and dichloromethylene diphosphonate (Cl 2 MDP) on the calcification and resorption of cartilage and bone in the tibial epiphysis and metaphysis of rats

6 December 2022

41

1 reference

https://api.crossref.org/works/10.1016/8756-3282(91)90062-N

Therapy of hypercalcemia due to parathyroid carcinoma with intravenous dichloromethylene diphosphonate

6 December 2022

42

1 reference

https://api.crossref.org/works/10.1016/8756-3282(91)90062-N

Effects of dichloromethylene diphosphonate on skeletal mobilization of calcium in multiple myeloma

6 December 2022

43

1 reference

https://api.crossref.org/works/10.1016/8756-3282(91)90062-N

Parathyroid hormonelike protein from human renal carcinoma cells. Structural and functional homology with parathyroid hormone

6 December 2022

44

1 reference

https://api.crossref.org/works/10.1016/8756-3282(91)90062-N

A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression

6 December 2022

45

1 reference

https://api.crossref.org/works/10.1016/8756-3282(91)90062-N

Clodronate. A randomized study in the treatment of cancer-related hypercalcemia

6 December 2022

48

1 reference

https://api.crossref.org/works/10.1016/8756-3282(91)90062-N

Rat parathyroid hormone-like peptide: comparison with the human homologue and expression in malignant and normal tissue

6 December 2022

49

1 reference

https://api.crossref.org/works/10.1016/8756-3282(91)90062-N

6 December 2022

Identifiers

1 reference

18 August 2017

1 reference